Login to Your Account



Gilead's Truvada Approved to Help Prevent HIV Infection

By Mari Serebrov
Washington Editor

Tuesday, July 17, 2012

The FDA approved Gilead Sciences Inc.'s Truvada as the first drug to help reduce the risk of contracting HIV-1, the most common form of HIV infection.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription